Skip to main content
Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
41.94
-1.84 (-4.20%)
At close: Mar 9, 2026

SHE:301281 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Mar '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2015
Market Capitalization
4,5423,2393,686---
Upgrade
Market Cap Growth
39.34%-12.13%----
Upgrade
Enterprise Value
4,3132,7863,045---
Upgrade
Last Close Price
41.9429.7333.44---
Upgrade
PE Ratio
86.7253.7447.85---
Upgrade
PS Ratio
10.436.998.24---
Upgrade
PB Ratio
3.312.382.77---
Upgrade
P/TBV Ratio
3.622.592.87---
Upgrade
P/OCF Ratio
--99.54---
Upgrade
EV/Sales Ratio
9.906.016.80---
Upgrade
EV/EBITDA Ratio
63.0333.2328.35---
Upgrade
EV/EBIT Ratio
146.8668.7352.07---
Upgrade
Debt / Equity Ratio
0.070.03----
Upgrade
Debt / EBITDA Ratio
1.430.54----
Upgrade
Net Debt / Equity Ratio
-0.17-0.28-0.51-0.29-0.15-0.11
Upgrade
Net Debt / EBITDA Ratio
-3.35-4.61-6.39-1.22-0.60-0.37
Upgrade
Net Debt / FCF Ratio
0.921.0820.72-1.76-2.07-0.38
Upgrade
Asset Turnover
0.280.310.420.730.830.77
Upgrade
Inventory Turnover
1.652.252.743.433.132.85
Upgrade
Quick Ratio
3.934.646.861.911.001.05
Upgrade
Current Ratio
5.635.777.912.621.841.77
Upgrade
Return on Equity (ROE)
3.84%4.48%8.33%19.20%20.24%22.33%
Upgrade
Return on Assets (ROA)
1.20%1.68%3.45%9.18%10.15%9.89%
Upgrade
Return on Invested Capital (ROIC)
2.48%4.47%11.13%22.44%21.47%20.31%
Upgrade
Return on Capital Employed (ROCE)
2.00%2.80%4.30%16.30%18.40%21.10%
Upgrade
Earnings Yield
1.15%1.86%2.09%---
Upgrade
FCF Yield
-5.46%-11.02%-0.90%---
Upgrade
Dividend Yield
0.46%0.67%0.90%---
Upgrade
Payout Ratio
46.15%54.03%40.16%--2.87%
Upgrade
Buyback Yield / Dilution
0.45%-6.18%-24.38%-0.53%0.47%-0.34%
Upgrade
Total Shareholder Return
0.91%-5.50%-23.48%-0.53%0.47%-0.34%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.